References
- Escribá PV, Nicolson GL. Biochimica et biophysica acta membrane structure and function: relevance of lipid and protein structures in cellular physiology, pathology and therapy. BBA – Biomembr. 2014;1838:1449–50. doi:10.1016/j.bbamem.2014.03.008.
- Kremmyda L-S, Tvrzicka E, Stankova B, Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease – a review. Part 2: fatty acid physiological roles and applications in human health and disease. Biomed Pap. 2011;155:195–218. doi:10.5507/bp.2011.052.
- Espinosa G, López-montero I, Monroy F, Langevin D. Shear rheology of lipid monolayers and insights on membrane fluidity. Proc Natl Acad Sci USA. 2011;108:6008–13. doi:10.1073/pnas.1018572108/-/DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1018572108.
- Schaeffer EL, Skaf HD, Novaes BDA, Silva ER, Martins BA, Joaquim HDG, et al. Progress in neuro-psychopharmacology & biological psychiatry inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1612–17. doi:10.1016/j.pnpbp.2011.05.001.
- Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging. 2005;26:98–102. doi:10.1016/j.neurobiolaging.2005.09.013.
- Comba A, Lin Y-H, Eynard AR, Valentich MA, Fernandez-Zapico ME, Pasqualini ME. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev. 2011;30:325–42. doi:10.1007/s10555-011-9308-x.
- Hwang J, Chang Y, Park JH, Kim SY, Chung H, Shim E. Dietary saturated and monounsaturated fats protect against acute acetaminophen hepatotoxicity by altering fatty acid composition of liver microsomal membrane in rats. Lipids Health Dis. 2011;10:184), doi:10.1186/1476-511X-10-184.
- Opperman M, Marais de W, Spinnler Benade AJ. Analysis of omega-3 fatty acid content of South African fish oil supplements. Cardiovasc J Afr. 2011;22:324–9. doi:10.5830/CVJA-2010-080.
- Estruch R, Martínez-González MÁ, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, et al. Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors. Ann Intern Med. 2006;145:1. doi:10.7326/0003-4819-145-1-200607040-00004.
- Uttara B, Singh A V, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7:65–74. doi: 10.2174/157015909787602823
- Catalá A. Lipid peroxidation modifies the picture of membranes from the ‘fluid mosaic model’ to the ‘lipid whisker model’. Biochimie. 2012;94:101–9. doi:10.1016/j.biochi.2011.09.025.
- Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington’s disease. Mov Disord. 2001;16:407–23. doi: 10.1002/mds.1096
- Roze E, Betuing S, Deyts C, Marcon E, Brami-Cherrier K, Pages C, et al. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death. FASEB J. 2007;22:1083–93. doi:10.1096/fj.07-9814.
- Tasset I, Pontes AJ, Hinojosa AJ, De TR, Túnez I. Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington’s disease-like rat model. Nutr Neurosci. 2011;14:106–11. doi: 10.1179/1476830511Y.0000000005
- Alconchel-Gago F, Santamaría A, Túnez I. Antioxidant effect of oleic acid and hydroxytyrosol in an experimental model similar to Huntington’s disease. Actual Medica. 2014;99:60–4. doi:10.15568/am.2014.792.or01.
- Morales-Martínez A, Sánchez-Mendoza A, Martínez-Lazcano JC, Pineda-Farías JB, Montes S, El-Hafidi M, et al. Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats. Nutr Neurosci. 2016;20:388–95. doi:10.1080/1028415X.2016.1147683.
- Clifford J, Drago J, Natoli A, Wong JY, Kinsella A, Waddington J, et al. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington’s disease. Neuroscience. 2002;109:81–8. doi:10.1016/S0306-4522(01)00409-2.
- Van Raamsdonk JM, Pearson J, Rogers DA, Lu G, Barakauskas VE, Barr AM, et al. Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease. Exp Neurol. 2005;196:266–72. doi:10.1016/j.expneurol.2005.07.021.
- Huntington Study Group TREND-HD Investigators. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease. Arch Neurol. 2008;65:1582–9. doi:10.1001/archneur.65.12.1582.
- Fukaya T, Gondaira T, Kashiyae Y, Kotani S. Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats. Neurobiol Aging. 2007;28:1179–86. doi:10.1016/j.neurobiolaging.2006.05.023.
- Yang X, Sheng W, He Y, Cui J, Haidekker MA, Sun GY, et al. Secretory phospholipase A 2 type III enhances-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity. J Lipid Res. 2010;51; doi:10.1194/jlr.M002287.
- Yang X, Sheng W, Sun GY, Lee JC. Neurochemistry international effects of fatty acid unsaturation numbers on membrane fluidity and a -secretase-dependent amyloid precursor protein processing. Neurochem Int. 2011;58:321–9. doi:10.1016/j.neuint.2010.12.004.
- Jhou J-F, Tai H-C. The study of postmortem human synaptosomes for understanding Alzheimer’s disease and other neurological disorders: a review. Neurol Ther. 2017;6:57–68. doi:10.1007/s40120-017-0070-z.
- Kucinski A, Paolone G, Bradshaw M, Albin RL, Sarter M. Modeling fall propensity in Parkinson’s disease: deficits in the attentional control of complex Movements in rats with cortical-cholinergic and striatal–dopaminergic deafferentation. J Neurosci. 2013;33:16522–39. doi:10.1523/JNEUROSCI.2545-13.2013.
- Parsons MP, Vanni MP, Woodard CL, Kang R, Murphy TH, Raymond LA. Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models. Nat Commun. 2016;7:11251), doi:10.1038/ncomms11251.
- Kamat PK, Kalani A, Tyagi N. Method and validation of synaptosomal preparation for isolation of synaptic membrane proteins from rat brain. MethodsX. 2014;1:102–7. doi:10.1016/j.mex.2014.08.002.
- Voss P, Thomas ME, Cisneros-franco JM, Alain C. Dynamic brains and the changing rules of neuroplasticity: implications for learning and recovery. Front Psychol. 2017;8:1–11. doi:10.3389/fpsyg.2017.01657.
- Hajós F. An improved method for the preparation of synaptosomal fractions in high purity. Brain Res. 1975;93:485–9. doi:10.1016/0006-8993(75)90186-9.
- Glossmann H, Neville DM. Gamma-glutamyltransferase in kidney brush border membranes. FEBS Lett. 1972;19:340–4. doi: 10.1016/0014-5793(72)80075-9
- Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497–509. doi: 10.1016/S0021-9258(18)64849-5
- El Hafidi M, Cuéllar A, Ramírez J, Baños G. Effect of sucrose addition to drinking water, that induces hypertension in the rats, on liver microsomal Delta9 and Delta5-desaturase activities. J Nutr Biochem. 2001;12:396–403. doi:10.1016/S0955-2863(01)00154-1.
- Silva VS, Cordeiro JM, Matos MJ, Oliveira CR, Gonçalves PP. Aluminum accumulation and membrane fluidity alteration in synaptosomes isolated from rat brain cortex following aluminum ingestion: effect of cholesterol. Neurosci Res. 2002;44:181–93. doi:10.1016/S0168-0102(02)00128-1.
- Eckert GP, Keller JH, Jourdan C, Karas M, Volmer DA, Schubert-Zsilavecz M, et al. Hyperforin modifies neuronal membrane properties in vivo. Neurosci Lett. 2004;367:139–43. doi:10.1016/j.neulet.2004.04.053.
- Pérez-Severiano F, Ríos C, Segovia J. Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease. Brain Res. 2000;862:234–7. doi:10.1016/S0006-8993(00)02082-5.
- Rios C, Santamaria A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res. 1991;16:1139–43. doi: 10.1007/BF00966592
- Ali SF, LeBel CP, Bondy SC. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology. 1992;13:637–48.
- Anderson EJ, Taylor DA. Stressing the heart of the matter: re-thinking the mechanisms underlying therapeutic effects of n-3 polyunsaturated fatty acids. F1000 Med Rep. 2012;4:13), doi:10.3410/M4-13.
- Wu Y, Tada M, Takahata K, Tomizawa K, Matsui H. Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells. Acta Med Okayama. 2007;61:147–52. doi:10.1017/CBO9781107415324.004.
- Schlame M, Ren M. The role of cardiolipin in the structural organization of mitochondrial membranes. Biochim Biophys Acta. 2009;1788:2080–3. doi:10.1016/j.bbamem.2009.04.019.
- Teague WE, Fuller NL, Rand RP, Gawrisch K. Polyunsaturated lipids in membrane fusion events. Cell Mol Biol Lett. 2002;7:262–4.
- Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015;7:52), doi:10.3389/fnagi.2015.00052.
- Chang C-Y, Ke D-S, Chen J-Y. Essential fatty acids and human brain. Acta Neurol Taiwan. 2009;18:231–41.
- Connor WE, Neuringer M, Lin DS. Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res. 1990;31:237–47. doi: 10.1016/S0022-2275(20)43209-2
- Connor WE, Neuringer M. The effects of n-3 fatty acid deficiency and repletion upon the fatty acid composition and function of the brain and retina. Prog Clin Biol Res. 1988;282:275–94.
- Carrié I, Clément M, de Javel D, Francès H, Bourre JM. Specific phospholipid fatty acid composition of brain regions in mice. Effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation. J Lipid Res. 2000;41:465–72. doi: 10.1016/S0022-2275(20)34485-0
- Chen CT, Domenichiello AF, Trépanier M-O, Liu Z, Masoodi M, Bazinet RP. The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms. J Lipid Res. 2013;54:2410–22. doi:10.1194/jlr.M038505.
- Huber T, Rajamoorthi K, Kurze VF, Beyer K, Briown MF. Structure of docosahexaenoic acid-containing phospholipids bilayer as studied by 1H NMR and molecular dynamics simulation. J Am Chem Soc. 2002;124:298–309. doi: 10.1021/ja011383j
- Cerezo J, Zúñiga J, Bastida A, Requena A, Cerón-Carrasco JP. Atomistic molecular dynamics simulations of the interactions of oleic and 2-hydroxyoleic acids with phosphatidylcholine bilayers. J Phys Chem B. 2011;115:11727–38. doi:10.1021/jp203498x.
- Hulbert AJ, Turner N, Storlien LH, Else PL. Dietary fats and membrane function: implications for metabolism and disease. Biol Rev Camb Philos Soc. 2005;80:155–69. doi: 10.1017/S1464793104006578
- Niu S-L, Mitchell DC, Lim S-Y, Wen Z-M, Kim H-Y, Salem N, et al. Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem. 2004;279:31098–104. doi:10.1074/jbc.M404376200.
- Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol. 2008;19:242–7. doi:10.1097/MOL.0b013e3282ffaf6a.
- Jump DB. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care. 2011;14:115–20. doi:10.1097/MCO.0b013e328342991c.
- Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med. 2000;192:1197–204. doi: 10.1084/jem.192.8.1197
- Sommer C, Birklein F. Resolvins and inflammatory pain. F1000 Med Rep. 2011;3:19), doi:10.3410/M3-19.